(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ORA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ORA

ST13

US500000097978199

Class

1, 5

Filing

97978199

Registration

7950819

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

04/03/2026

Trademark type

Combined

Nice classes

1, 5

Filing date

04/20/2023

Registration date

09/16/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/16/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/19/2023

First use in commerce

10/19/2024

Drawing code

5

Owner type

03

Owner location

Zhubei, Hsinchu County, TW

Examiner

YOUNG, THOMAS PAUL

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word, "ora", in a stylized font.

Holders and representatives

Holders

Inti Taiwan, Inc.

Representatives

Chinhwei Chen Jianq Chyun Intellectual Property Office

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Bacterial preparations other than for medical and veterinary use; Chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; Industrial chemicals; Biological preparations for use in industry and sciencenot for medical or veterinary purposes; Chemical preparations for scientific purposesother than for medical or veterinary use; Cultures of microorganismsother than for medical and veterinary use; Chemicals for use in science; Nucleic acid amplification reagents for scientific and research usenot for medical use; Reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) for scientific and research usenot for medical or veterinary purposes; Chemical reagents for genetic identity testingnot for medical purposes; Chemical reagents for use in diagnostic testsother than for medical or veterinary use; Chemical reagents for use in analytical testsother than for medical or veterinary use; Chemical reagents for non-medical purposes; Enzymes for detecting proteins for scientific purposesother than for medical use; Biochemical testing reagents other than for medical purposes; Chemical reagents for laboratory useother than for medical or veterinary use; Chemical reagents for use in genetic research; Chemical reagents for genetic identity testingfor research purposes; Testing reagents for scientific use; Kits comprising chemicals for use in industry for sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingduplicatingsequencing and for the analysis of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids and biological and biochemical sample materialindustrial chemicals for reagentsenzymes and buffer solutions for nucleic acid purificationenrichmentamplificationsequencing and analysisnot for medical purposes; Clinical diagnostic reagents for scientific or research use; Diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiologyfor scientific use; Chemicalbiochemical and biotechnological products for commercial and scientific usebuffer solutionsnucleic acidsnucleic acid derivatives and proteins for chemical analysisnot for medical or veterinary purposes

Class 5

Enzyme preparations for medical purposes; Bacterial preparations for medical purposes; Medical diagnostic assays for testing of bodily fluids and tissue in the detectionmonitoringprediction of disease or other conditionsdisease stateshormone leveldrug leveldrug responseorgan function effectivenessclinical response; Reagents for use in diagnostic tests for medical purposes; Diagnostic biomarker reagents for medical purposes; Reagent paper for medical purposes; Clinical diagnostic reagents for medical use; Chemical test reagents for medical use; Chemical reagentsdiagnostic medical reagent strips for use by individuals to test their own body fluids and for use by the medical profession; Reagents for use in medical genetic testing; Genetic identity tests comprised of reagents for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical purposes

Publications

History of USPTO decisions and trademark events.

29 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/16/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

09/16/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/03/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/28/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/12/2025

IUAF

USE AMENDMENT FILED

02/19/2025

EISU

TEAS STATEMENT OF USE RECEIVED

02/19/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/03/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/09/2024

PUBO

PUBLISHED FOR OPPOSITION

07/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/19/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/06/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

06/05/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/05/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

06/05/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/05/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

05/08/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/07/2024

DRRR

DIVISIONAL REQUEST RECEIVED

04/11/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/11/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/11/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/11/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

04/11/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/18/2024

GNRT

NON-FINAL ACTION E-MAILED

01/18/2024

CNRT

NON-FINAL ACTION WRITTEN

01/18/2024

DOCK

ASSIGNED TO EXAMINER

01/18/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/16/2023

NWAP

NEW APPLICATION ENTERED

04/24/2023

Continuous trademark protection

Get notified about every new filing that threatens ORA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.